Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
The companys behavioral science team has been gathering data since the September launch of its Noom GLP-1 Rx product to support claims related to the following dimensions: Improved medication persistence , measured as total weeks adhered Improved medication adherence , measured as % of doses skipped Decreased side effect prevalence , measured as incidence rate and severity Improved lean muscle mass preservation , measured through Noom Body Scan Improved weight loss outcomes across a full sample of study participants "Every day, we're focused on helping people everywhere to live better longer, and entering into the PDURS space is an important next step in making that happen," continued Cook
Use of GLP-1 agonists is increasing both through NHS and private prescriptions
Persistent accumulation of damaged mitochondria due to impaired mitophagy is a likely antecedent to neurodegenerative disease
GLP-1 agonists work by mimicking the incretin hormone GLP-1 , which enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite
Pattappa G, Krueckel J, Schewior R, Franke D, Mench A, Koch M, Weber J, Lang S, Pfeifer CG, Johnstone B, Docheva D, Alt V, Angele P, Zellner J
Sci Pract Perspect
US$ 21.04
US$ 23.94
US$ 27.21
US$ 27.62
US$ 20.17
US$ 26.92
US$ 20.11
US$ 24.92
